Evidence map›Paper›PMID 42748658›Full record

ReviewRedox biology2026

Experimental workflows for the accurate identification of mitochondrial redox events.

Pablo Hernansanz-Agustín, Juan Pedro Bolaños, Consuelo Borrás, Elisa Cabiscol, Victoria Campuzano, Laura de Cubas, José Antonio Enríquez, Isabel Fabregat, Gemma Gonfaus-Ortiz, Elena Hidalgo and 8 more

Abstract readReview
In one paragraph

Review in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Pablo Hernansanz-AgustínCentro de Neurociencias Cajal (CNC), Consejo Superior de Investigaciones Científicas (CSIC), Avenida de León 1, Alcalá de Henares, 28805, Spain. Electronic address: pablo.hernansanz@csic.es.
Juan Pedro BolañosInstitute of Functional Biology and Genomics, University of Salamanca, CSIC, Salamanca, 37007, Spain; Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), Spain; Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, University of Salamanca, CSIC, Salamanca, 37007, Spain.
Consuelo BorrásCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), Spain; MiniAging/Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, Institute of Health Research-INCLIVA, Valencia, 46010, Spain.
Elisa CabiscolDept. Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida, Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain; Institut de Recerca Biomèdica de Lleida Fundació Dr. Pifarré (IRBLleida), Av. Alcalde Rovira Roure 80, Lleida, 25198, Spain.
Victoria CampuzanoDepartment de Biomedical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, 08036, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain; Centro de Investigación Biomédica en Red Enfermedades Raras-Instituto de Salud Carlos III (CIBERER-ISCIII), Spain.
Laura de CubasOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, C/ Dr. Aiguader 88, 08003, Barcelona, 08908, Spain.
José Antonio EnríquezCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), Spain; Cardiovascular Regeneration Program, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, 28029, Spain.
Isabel FabregatTGF-β and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08908, Spain; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas-Instituto de Salud Carlos III (CIBERHED-ISCIII), Spain.
Gemma Gonfaus-OrtizTGF-β and Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, 08908, Spain; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas-Instituto de Salud Carlos III (CIBERHED-ISCIII), Spain.
Elena HidalgoOxidative Stress and Cell Cycle Group, Universitat Pompeu Fabra, C/ Dr. Aiguader 88, 08003, Barcelona, 08908, Spain.
Marc LiesaInstitut de Biologia Molecular de Barcelona (IBMB) CSIC, Barcelona, Spain; CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain.
Cristina Mas-BarguesCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable-Instituto de Salud Carlos III (CIBERFES-ISCIII), Spain; MiniAging/Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, Institute of Health Research-INCLIVA, Valencia, 46010, Spain.
Antonio Martínez-RuizUnidad de Investigación, Hospital Universitario Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Madrid, 280009, Spain.
María MonsalveInstituto de Investigaciones Biomédicas Sols-Morreale (CSIC-UAM), Arturo Duperier, 4, Madrid, 28029, Spain.
Rubén Quintana-CabreraCentro de Neurociencias Cajal (CNC), Consejo Superior de Investigaciones Científicas (CSIC), Avenida de León 1, Alcalá de Henares, 28805, Spain.
Sergio Rius-PérezDepartment of Cell Biology and Functional Biology, Faculty of Biology, University of Valencia, Valencia, Spain.
Juan SastreDepartment of Physiology, Faculty of Pharmacy & Food Sciences, University of Valencia, Avda. Vicente Andrés Estellés 22, Burjasot, Valencia, 46100, Spain.
Antonio ZorzanoCIBERDEM, Instituto de Salud Carlos III, Madrid, Spain; Institute for Research in Biomedicine (IRB Barcelona), Department of Biochemistry and Molecular Medicine, Universitat de Barcelona, Barcelona, 08028, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study of redox biology has been growing constantly since the last decades. Over these years, redox processes have been linked to an extraordinarily wide range of physiological and pathological events, becoming recognized as central mechanisms underlying many of them. In this context, it becomes essential to understand the advantages and limitations of the tools under use, to recognize the specific controls required for each measurement and to accurately distinguish between distinct redox mechanisms. So far, multiple and excellent reviews have dealt with either the tools, the protocols or the mechanisms involved in reactive oxygen species (ROS) production and quenching, a.k.a. redox events. However, a review outlining the workflows to appropriately detect them is still lacking. We define workflow as the combination of tools, methods and mechanistic knowledge that allow the definition of a specific redox event. In this review, we aim to provide an optimal workflow for the research on mitochondrial redox events. To this end, we first summarize the molecular tools available to measure and quench ROS. We then explain the mechanisms of ROS production and scavenging in several of the cellular compartments, with special focus on mitochondria, as well as their implication in physiology and disease. Finally, we use the knowledge in all sections to build a recommended experimental workflow, illustrated by several cases of study. This review will enable the reader to understand how specific mitochondrial redox events can be accurately measured, considering all technical, methodological and mechanistical variables and limitations required for their reliable detection and interpretation.

Indexed as

AntioxidantMitochondrial ROS(Patho)physiologyRedox eventROS probeWorkflow

Identifiers

PMID42748658
PMCPMC13595005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.